SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jim black who wrote (27493)1/16/2003 11:57:13 AM
From: Maurice Winn  Read Replies (1) of 74559
 
Hi Jim. Re Avodart, I had a brief look at its hair loss prevention, impotence causing, and prostate and PSA shrinkage as well as a few other effects. fda.gov

fda.gov

Also, I had a quick look at Glaxo Smith Kline.

A few comments:

Avodart is small in relation to GSK's overall business and market capitalisation, so it's not going to block bust their profits skywards. Once upon a time [1987] I got really excited about Philips Electronics which had invented CD-ROMs which I thought would take over the world. CD-ROMs did replace tapes and records and gained huge markets in other data delivery applications [such as software]. But Philips was simply too big to gain a major effect, especially when they were gushing the money out the back door as fast as it came in the front. My guess is that Avodart is similar, though not as popular as CD-ROMs.

The market for Avodart is for some older males who are not long for this world anyway and who don't mind the drawbacks of this stuff.

I doubt it'll bring hair back on bald men [the claim is to prevent hair loss].

Mqurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext